BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28796538)

  • 1. Oxygen Therapy for Interstitial Lung Disease: Physicians' Perceptions and Experiences.
    Khor YH; Goh NSL; McDonald CF; Holland AE
    Ann Am Thorac Soc; 2017 Dec; 14(12):1772-1778. PubMed ID: 28796538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen Therapy for Interstitial Lung Disease. A Mismatch between Patient Expectations and Experiences.
    Khor YH; Goh NSL; McDonald CF; Holland AE
    Ann Am Thorac Soc; 2017 Jun; 14(6):888-895. PubMed ID: 28267349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen for interstitial lung diseases.
    Khor YH; Smith DJF; Johannson KA; Renzoni E
    Curr Opin Pulm Med; 2020 Sep; 26(5):464-469. PubMed ID: 32657832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.
    Johannson KA; Pendharkar SR; Mathison K; Fell CD; Guenette JA; Kalluri M; Kolb M; Ryerson CJ
    Ann Am Thorac Soc; 2017 Sep; 14(9):1373-1377. PubMed ID: 28644693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.
    Faverio P; De Giacomi F; Bonaiti G; Stainer A; Sardella L; Pellegrino G; Sferrazza Papa GF; Bini F; Bodini BD; Carone M; Annoni S; Messinesi G; Pesci A
    Int J Med Sci; 2019; 16(7):967-980. PubMed ID: 31341410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domiciliary oxygen therapy services in Tasmania: prescription, usage and impact of a specialist clinic.
    Jones A; Wood-Baker R; Walters EH
    Med J Aust; 2007 Jun; 186(12):632-4. PubMed ID: 17576179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental Oxygen Therapy in Interstitial Lung Disease: A Narrative Review.
    Clark KP; Degenholtz HB; Lindell KO; Kass DJ
    Ann Am Thorac Soc; 2023 Nov; 20(11):1541-1549. PubMed ID: 37590496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia.
    Serginson JG; Yang IA; Armstrong JG; Cooper DM; Matthiesson AM; Morrison SC; Gair JM; Cooper B; Zimmerman PV
    Med J Aust; 2009 Nov; 191(10):549-53. PubMed ID: 19912087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.
    Ora J; Coppola A; Perduno A; Manzetti GM; Puxeddu E; Rogliani P
    Monaldi Arch Chest Dis; 2021 Oct; 92(2):. PubMed ID: 34634897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Sørensen SR; Bendstrup E; Davidsen JR
    Ugeskr Laeger; 2022 Nov; 184(46):. PubMed ID: 36426814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.
    Mas Dalmau G; Sant Arderiu E; Enfedaque Montes MB; Solà I; Pequeño Saco S; Alonso Coello P
    BMC Fam Pract; 2017 Jan; 18(1):3. PubMed ID: 28086887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study.
    Ahmadi Z; Wysham NG; Lundström S; Janson C; Currow DC; Ekström M
    Thorax; 2016 Jun; 71(6):510-6. PubMed ID: 26865603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease and pulmonary rehabilitation.
    Garvey C
    J Cardiopulm Rehabil Prev; 2010; 30(3):141-6. PubMed ID: 20040881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.
    Morisset J; Dubé BP; Garvey C; Bourbeau J; Collard HR; Swigris JJ; Lee JS
    Ann Am Thorac Soc; 2016 Jul; 13(7):1026-33. PubMed ID: 27064659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domiciliary oxygen for interstitial lung disease.
    Crockett AJ; Cranston JM; Antic N
    Cochrane Database Syst Rev; 2001; 2001(3):CD002883. PubMed ID: 11687030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplemental oxygen for the management of dyspnea in interstitial lung disease.
    Schaeffer MR; Molgat-Seon Y; Ryerson CJ; Guenette JA
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):174-178. PubMed ID: 31145136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better Together: A Mixed-Methods Study of Palliative Care Co-Management for Patients with Interstitial Lung Disease.
    Bischoff KE; Choi S; Su A; Cohen E; O'Riordan DL; Oettel E; Blachman M; Meister S; Zapata C; Lindenfeld P; Calton B; Witt L; Pantilat SZ; Shah RJ
    J Palliat Med; 2021 Dec; 24(12):1823-1832. PubMed ID: 34115958
    [No Abstract]   [Full Text] [Related]  

  • 18. Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union.
    Takizawa A; Kamita M; Kondoh Y; Bando M; Kuwana M; Inoue Y
    Curr Med Res Opin; 2021 Feb; 37(2):327-339. PubMed ID: 33287583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Be honest and help me prepare for the future: What people with interstitial lung disease want from education in pulmonary rehabilitation.
    Holland AE; Fiore JF; Goh N; Symons K; Dowman L; Westall G; Hazard A; Glaspole I
    Chron Respir Dis; 2015 May; 12(2):93-101. PubMed ID: 25687210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease.
    Ramadurai D; Riordan M; Graney B; Churney T; Olson AL; Swigris JJ
    Respir Med; 2018 May; 138():32-37. PubMed ID: 29724390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.